Pulling SEC filings + quote and writing the call…

TEXAS INSTRUMENTS INC
Next earnings Jul 20, 2026 (after close) · consensus $1.95 EPS, $5.30B rev
Last earnings +1.4% on 2026-04-22
Elite analog franchise riding a real cyclical upturn, but a 59x P/E and a dividend that outruns free cash flow leave no margin of safety.
P/E (price / FY diluted EPS $5.45) 59.2 · current price / FY2025
Middling fundamentals and a rich price (~54% above fair value) leave little margin of safety — a wait-and-see.
Texas Instruments is exactly the kind of business the market loves to overpay for, and right now it is overpaying. The franchise quality is undeniable: 57.0% gross margin, 34.1% operating margin, 30.7% ROE, and $7.15B of operating cash flow (+13.2%) thrown off by a portfolio the 10-K frames around four durable advantages — owned 300mm manufacturing, breadth of analog/embedded parts, channel reach, and product longevity. FY2025 also confirms the cyclical trough is behind it: revenue rebounded +13.0% to $17.7B off the $15.6B 2024 low. This is a high-quality compounder you can comfortably own through a cycle.
The problem is price versus where earnings actually are. At $322.86 (after a +6.95% pop today) the stock trades at 59.2x trailing EPS and 16.6x sales, yet net income of $5.00B is still 43% below the 2022 peak of $8.75B and below 2021's $7.77B — and it grew just 4.2%. Free cash flow was only $2.94B (16.6% of revenue), a ~1% FCF yield against a $293B market cap. At today's price the stock effectively discounts a full return to peak earnings; if the recovery merely normalizes rather than re-accelerates, the multiple has nowhere to go but down.
AI-generated analysis, produced by our proprietary engine from SEC filing data.
Investment recommendation produced by TENK/calls (tenkcalls.com), Luxembourg. Completed Jun 19, 2026, 2:02 PM ET. Ratings & methodology: definitions · All recommendations to date: track record · Conflicts: disclosures. Not investment advice.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $18.3B | $20.0B | $17.5B | $15.6B | $17.7B |
| Gross profit | $12.4B | $13.8B | $11.0B | $9.09B | $10.1B |
| Operating income | $8.96B | $10.1B | $7.33B | $5.46B | $6.02B |
| Net income | $7.77B | $8.75B | $6.51B | $4.80B | $5.00B |
| Diluted EPS | $8.26 | $9.41 | $7.07 | $5.20 | $5.45 |
| Net margin | 42.4% | 43.7% | 37.2% | 30.7% | 28.3% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Officer/director change (Item 5.02); leadership transition, no stated financial impact
Q1 2026 10-Q; demand recovery sustained, margins aided by 300mm fab loading
Q1 2026 results released; revenue recovery off the 2024 cyclical trough continues
Annual meeting vote results filed; directors elected, routine governance items
Officer/director change announced (Item 5.02); leadership transition
Annual proxy; exec comp and board slate up for shareholder vote
FY2025 10-K: revenue $17.7B (+13%), EPS $5.45; cyclical recovery, capex easing
FY2025 10-K: revenue $17.7B (+13%), EPS $5.45; cyclical recovery, capex easing
Reg FD capital-management update; reaffirms FCF/share focus & shareholder returns
Sources: SEC EDGAR (CIK 0000097476, latest 10-Q filed 2026-04-24) · EODHD · Proprietary analysis · as of 6/19/2026, 6:02:35 PM.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
Last 90 days: 0 open-market buys · 9 sales
| 2026-05-28 | Craighead Martin S Director | Sell | 9.64K @ $320.41 | $3.09M |
| 2026-05-28 | Craighead Martin S Director | Sell | 357.00 @ $321.01 | $115K |
| 2026-05-14 | BAHAI AHMAD Sr. Vice President | Exercise | 5.00K @ $110.15 | $551K |
| 2026-05-14 | BAHAI AHMAD Sr. Vice President | Sell | 5.00K @ $309.13 | $1.55M |
| 2026-05-14 | Lizardi Rafael R Sr. Vice President & CFO | Exercise | 47.7K @ $174.81 | $8.34M |
| 2026-05-14 | Lizardi Rafael R Sr. Vice President & CFO | Sell | 32.1K @ $307.85 | $9.89M |
| 2026-05-14 | Lizardi Rafael R Sr. Vice President & CFO | Sell | 14.2K @ $308.54 | $4.37M |
| 2026-05-14 | Lizardi Rafael R Sr. Vice President & CFO | Sell | 1.46K @ $309.45 | $451K |
| 2026-05-13 | COX CARRIE SMITH Director | Exercise | 4.31K @ $110.15 | $474K |
| 2026-05-13 | COX CARRIE SMITH Director | Exercise | 4.53K @ $104.41 | $473K |
| 2026-05-13 | COX CARRIE SMITH Director | Sell | 8.39K @ $306.37 | $2.57M |
| 2026-05-13 | COX CARRIE SMITH Director | Sell | 445.00 @ $307.04 | $137K |
Source: EODHD. Yield = trailing-12-month dividends ÷ price.
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
1 buy · 2 sells · 3 members · last 180d
Self-reported periodic transaction reports (STOCK Act). Amounts are disclosed ranges; a trade may be a spouse's. Disclosures lag the trade by up to ~45 days. Source: House Clerk + Senate eFD.
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.